DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE6052.0042 (+0.7 %)
PREV CLOSE ( ) 6010.00
OPEN PRICE ( ) 6017.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9158
TODAY'S LOW / HIGH ( )5987.00 6071.00
52 WK LOW / HIGH ( )4383.4 6505.5
NSE6050.3539.5 (+0.66 %)
PREV CLOSE( ) 6010.85
OPEN PRICE ( ) 6005.85
BID PRICE (QTY) 6050.35 (21)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 408298
TODAY'S LOW / HIGH( ) 5985.05 6073.85
52 WK LOW / HIGH ( )4384.05 6505.9
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax60485.0030614.0028835.0018857.0023358.00
Adjustment16959.0023338.0020872.0025625.008350.00
Changes In working Capital-7855.00-18407.00-8288.00-7536.001837.00
Cash Flow after changes in Working Capital69589.0035545.0041419.0036946.0033545.00
Cash Flow from Operating Activities58875.0028108.0035703.0029841.0028704.00
Cash Flow from Investing Activities-41373.00-26387.00-22660.00-4923.00-7727.00
Cash Flow from Financing Activities-26861.00-2422.00-298.00-25159.00-21326.00
Net Cash Inflow / Outflow-9359.00-701.0012745.00-241.00-349.00
Opening Cash & Cash Equivalents14852.0014820.001962.002228.002542.00
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations286.00733.00113.00-25.0035.00
Closing Cash & Cash Equivalent5779.0014852.0014820.001962.002228.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.